Testosterone undecanoate (oral, LPCN 1021)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Testosterone undecanoate (oral, LPCN 1021), covering 2019-09-11 to 2019-09-11. Get the full timeline:
Most recent: Clinical Trial Update: Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021) [Phase 3]